These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32632387)

  • 21. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .
    Samji NS; Heda R; Satapathy SK
    Transl Gastroenterol Hepatol; 2020; 5():10. PubMed ID: 32190778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Said A; Ghufran A
    World J Clin Oncol; 2017 Dec; 8(6):429-436. PubMed ID: 29291167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
    Ong J; Younossi ZM
    Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation.
    Mikolasevic I; Orlic L; Hrstic I; Milic S
    Hepatol Res; 2016 Aug; 46(9):841-52. PubMed ID: 26713425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.
    Koh YX; Tan HJ; Liew YX; Syn N; Teo JY; Lee SY; Goh BKP; Goh GBB; Chan CY
    J Am Coll Surg; 2019 Nov; 229(5):467-478.e1. PubMed ID: 31398386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for non-alcoholic fatty liver disease.
    Germani G; Becchetti C
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):138-146. PubMed ID: 29249127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NAFLD: a multisystem disease.
    Byrne CD; Targher G
    J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas M; Imprialos K; Stavropoulos K; Athyros VG
    Curr Vasc Pharmacol; 2019; 17(5):425-428. PubMed ID: 31418344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.
    Su R; Wei X; Wei Q; Lu D; Lin Z; Wang S; Shao C; Xu X
    Hepatobiliary Surg Nutr; 2022 Jun; 11(3):400-411. PubMed ID: 35693397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
    Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
    Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
    Tokushige K; Hashimoto E; Kodama K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain.
    Legaz I; Navarro-Noguera E; Bolarín JM; García-Alonso AM; Luna Maldonado A; Mrowiec A; Campillo JA; Gimeno L; Moya-Quiles R; Álvarez-López Mdel R; Minguela Puras A; Miras M; Sánchez-Bueno F; Muro M
    Alcohol Clin Exp Res; 2016 Apr; 40(4):794-805. PubMed ID: 27012317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.
    Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Padilla Machaca M; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Podestá LG; McCormack L; Gadano A; Boin ISFF; García P; Silva M;
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):443-452. PubMed ID: 29773419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease and cardiovascular disease.
    Hyogo H; Chayama K; Yamagishi S
    Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease.
    O'Neill S; Napetti S; Cornateanu S; Sutherland AI; Wigmore S; Oniscu GC; Adair A
    HPB (Oxford); 2017 Dec; 19(12):1074-1081. PubMed ID: 28888774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease.
    Kalogirou MS; Giouleme O
    World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.